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Tonic GABA type A (GABAA) conductance is a key factor regulating neuronal excitability
and computation in neuronal networks. The magnitude of the tonic GABAA conductance
depends on the concentration of ambient GABA originating from vesicular and
non-vesicular sources and is tightly regulated by GABA uptake. Here we show that the
transport system regulating ambient GABA responsible for tonic GABAA conductances
in hippocampal CA1 interneurons depends on its source. In mice, GABA from vesicular
sources is regulated by mouse GABA transporter 1 (mGAT1), while that from non-vesicular
sources by mouse GABA transporters 3/4 (mGAT3/4). This finding suggests that the
two transporter systems do not just provide backup for each other, but regulate distinct
signaling pathways. This allows individual tuning of the two signaling systems and
indicates that drugs designed to act at specific transporters will have distinct therapeutic
actions.
Keywords: GABA transporter, tonic GABAA conductance, mutant α-latrotoxin, GABA source, extrasynaptic
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INTRODUCTION
Tonic activation of extrasynaptic GABA type A receptors
(GABAA) by ambient GABA is a major form of GABAergic sig-
naling in the central nervous system (Semyanov et al., 2004;
Farrant and Nusser, 2005; Glykys and Mody, 2007a; Walker and
Semyanov, 2008). It can be recorded in voltage-clamped neu-
rons as the part of holding current (Ihold) that is sensitive to
GABAA receptor antagonists (termed tonic GABAA current).
The expression of tonic GABAA currents is cell-type specific,
and this specificity determines the network effect of this form
of signaling (Semyanov et al., 2004). For example, in the hip-
pocampal CA1 region, tonic GABAA currents are significantly
larger in interneurons than in pyramidal cells (Semyanov et al.,
2003; Scimemi et al., 2005), and this difference may be due to a
more efficient GABA uptake around pyramidal cells. Tonic cur-
rents also exert different effects on interneuron and pyramidal
cell excitability. In the adult brain, GABA hyperpolarizes hip-
pocampal pyramidal neurons (Glickfeld et al., 2009), whereas it
depolarizes interneurons (Michelson andWong, 1991; Banke and
McBain, 2006; Vida et al., 2006; Song et al., 2011). Consequently,
tonic GABAA conductances have inhibitory effects on pyramidal
neurons, whereas low tonic GABAA conductances have exci-
tatory effects on interneurons (Song et al., 2011). When the
ambient GABA concentrations increase, tonic GABAA conduc-
tances become larger and the shunting overpowers the exci-
tatory effect of depolarization, rendering the overall effect of
the tonic GABAA conductance inhibitory. This phenomenon is
particularly interesting given the diverse roles of interneurons
in the hippocampus, such as rhythmic activity, synchronization
of pyramidal cells firing, feedforward, and feedback inhibition
(see for review, Kullmann, 2011). Thus mechanisms chang-
ing ambient GABA concentrations around interneurons, such
as GABA release and uptake, can have profound functional
effects. Ambient GABA originates from a number of synaptic
and non-synaptic sources in the brain. The magnitude of tonic
GABAA currents in rat CA1 pyramidal neurons correlates with
the frequency of spontaneous inhibitory post-synaptic currents
(sIPSCs) when rat GAT1 (rGAT1) is blocked, suggesting a synap-
tic contribution to ambient GABA around these cells (Glykys
and Mody, 2007b). Astrocytic GABA release has been demon-
strated in the olfactory bulb (Kozlov et al., 2006) and cerebellum
(Lee et al., 2010). Dendritic exocytotic GABA release has been
reported in the neocortex (Zilberter et al., 1999). Extracellular
GABA is cleared by GABA transporters, classified as mouse
GABA transporter 1 (mGAT1), mGAT2, mGAT3, and mGAT4
in the mouse [homologs in rat: mGAT1 ∼ rGAT1, mGAT2 ∼
betaine/GABA transporter 1 (BTG1), mGAT3 ∼ rGAT2, mGAT4
∼ rGAT3]. In rats, rGAT1 and rGAT2/3 blockers synergisti-
cally modulate tonic GABAA conductances (Keros and Hablitz,
2005; Jin et al., 2011). The relative impact of different trans-
porters on ambient GABA originating from different sources,
however, has been unknown. Here we show in mouse hippocam-
pal CA1 stratum (str.) radiatum interneurons that mGAT1 and
mGAT3/4 selectively regulate tonic GABAA currents mediated
by GABA originating from vesicular and non-vesicular sources,
respectively.
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MATERIALS AND METHODS
ETHICAL APPROVAL
All procedures involving animals were approved by the institu-
tional Animal Care and Use committee at RIKEN.
SLICE PREPARATION
Hippocampal slices (350μm) were obtained from 3- to 4-week-
old C57BL/6J mice. After dissection, the hippocampi were sliced
using a vibration microtome (Microm HM650V, Germany).
Transverse hippocampal slices were prepared in ice-cold slic-
ing solution containing (in mM): 87NaCl, 2.5 KCl, 7MgCl2,
0.5 CaCl2, 26.2NaHCO3, 1.25NaH2PO4, 25 glucose, and 50
sucrose, and saturated with 95% CO2/5% O2. After preparation,
the slices were maintained at room temperature in a submerged
chamber with storage solution containing (in mM): 119NaCl,
2.5 KCl, 1.3MgSO4, 1 CaCl2, 26.2NaHCO3, 1NaH2PO4, and 11
glucose, and saturated with 95% CO2/5% O2.
WHOLE-CELL PATCH CLAMP RECORDING
After 1 h incubation, slices were transferred to the recording
chamber and superfused at 32–34◦C with external solution
(same as above, but containing 2.5mM CaCl2). AMPA/kainate,
NMDA, and GABAB receptors were blocked with 25μM NBQX,
50μMAPV, and 5μMCGP52432 (Tocris Cookson, Bristol, UK),
respectively.
α-Latrotoxin from the black widow spider venom stimu-
lates neurotransmitter release by acting on presynaptic receptors
(Ushkaryov et al., 2008; Silva et al., 2009). α-Latrotoxin mutant
(LTXN4C) in which four amino acids were inserted between
the main domains (Ichtchenko et al., 1998) was used to stim-
ulate spontaneous vesicular exocytosis (Volynski et al., 2003).
Stock aliquots of LTXN4C (17–42 nM) were stored at −28◦C
in non-freon Nihon freezer GS-1356HC (Japan). LTXN4C was
focally applied to the recording chamber at a concentration
of 0.1 nM near the recording pipette after stopping the super-
fusion (Capogna et al., 2003). Perfusion was resumed when
the frequency of sIPSCs began to increase (0.5–10min after
toxin application). Such an interruption in perfusion had no
effect on control recordings. In experiments where vesicular
release was blocked, slices were pre-treated for at least 2.5 h
in 4μM bafilomycin A1 (Wako Chemicals, Japan) while con-
trol slices from the same animal were kept in external solution
without bafilomycin A1. All recordings were made from CA1
str.radiatum interneurons visually identified with an infrared dif-
ferential interference contrast microscope (Olympus BX51WI,
Japan).Whole-cell pipettes used in voltage-clamp recordings con-
tained (in mM): 130 CsCl, 8NaCl, 10Cs-HEPES, 2 EGTA, 0.2
MaCl2, 2MgATP, 0.3 Na3GTP, and 5 QX314Br (pH 7.2, osmolar-
ity 295 mOsm). The data were acquired with a Multiclamp700B
amplifier (Molecular Devices, Sunnyvale, CA), filtered at 3 kHz,
and digitized at 10 kHz using a NI PCI-6221 data acquisition card
(National Instruments, Austin, TX). The data were analyzed with-
out further re-sampling. Sample traces were also taken at the same
rate; the long traces (>30 s) showing the Ihold were re-sampled at
10Hz for illustration purposes. Frequency, amplitude, and area
of sIPSCs were analyzed off-line with MiniAnalysis (Synaptosoft
Inc, Decatur, GA) and Clampfit (Molecular Devices) programs.
Whole-cell voltage-clamp recordings were performed
at −70mV. Tonic GABAA currents (Ihold) were calculated as
the difference between the baseline Ihold and the Ihold in the
presence of the drug affecting tonic GABAA currents. To estimate
Ihold in control and drug conditions, we plotted all-points
histograms over 20 s of recordings in each case (Glykys and
Mody, 2007b). These histograms have a peak which corresponds
to mean Ihold while fluctuations in the holding current affect
the width and skewness of the histograms. This method was
specifically developed to overcome bias due to the presence of
IPSCs on the Ihold measurements. The time-averaged currents
mediated by sIPSCs (Ispont) were calculated as the mean charge
transfer of sIPSCs (area under the IPSCs) multiplied by their
frequency (Semyanov et al., 2003).
STATISTICS
Statistical analysis was performed using Excel (Microsoft,
USA) and Origin8 (OriginLab, USA). Data were presented as
mean ± S.E.M; ∗P < 0.05, ∗∗P < 0.01 paired, unpaired, or one-
sample Student’s t-test as stated in the text. A P-value of less than
0.05 was considered statistically significant. Two-Way ANOVA
was used to assess the effects and interaction of GABA transporter
blockers and bafilomycin A1.
RESULTS
TONIC GABAA CONDUCTANCE IS REGULATED BY BOTH mGAT1
AND mGAT3/4 TRANSPORTERS
sIPSCs and Ihold were recorded in voltage-clamped CA1
str.radiatum interneurons in mouse hippocampal slices in the
presence of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid (AMPA)/kainate, N-methyl-D-aspartate (NMDA), and
GABA type B (GABAB) receptor antagonists to isolate GABAA
receptor currents. The transient inward currents were mediated
by GABAA receptors (sIPSCs) and blocked by application of
the GABAA receptor antagonist picrotoxin (100μM; Figure 2A).
Picrotoxin also produced a shift in Ihold, which represents the
tonic GABAA current. Then we tested how different transporter
subtypes regulate this baseline tonic GABAA current. The mGAT1
blocker NO711 (10μM) and the mGAT3/4 blocker SNAP5114
(100μM) both significantly increased Ihold (Table 1, Figure 1),
suggesting that elimination of either transporter subtype leads
to increases in ambient GABA. NO711 and SNAP5114 together
increased Ihold more than the sum of the effects of individual
Table 1 | Effect of mGAT1 and mGAT3/4 blockers on Ihold in mouse
interneurons.
Ihold
(NO711)
Ihold
(SNAP5114)
P (NO711 vs.SNAP5114)
Control 19.35 ± 5.09
(n = 6)
12.12 ± 2.28
(n = 7)
0.100
Bafilomycin A1 7.56 ± 1.74
(n = 6)
17.03± 4.02
(n = 6)
0.028∗
P(controlvs.baf.A1) 0.026∗ 0.149
Data are presented as mean ± S.E.M; P-values for unpaired t-test, *P < 0.05.
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blockers suggesting a synergetic effect of the two drugs on extra-
cellular GABA elevation.
TONIC GABAA CONDUCTANCE IS MEDIATED BY GABA RELEASED
FROM BOTH VESICULAR AND NON-VESICULAR SOURCES
It was unclear whether GABA elevations during blockade of
each transporter system originated from the same or different
sources. Indeed, the different locations of rGAT1 (which is pre-
dominantly located on neurons) and rGAT3 (which is located
on astrocytes) indicate that these transporters may specifically
regulate GABA originating from different sources (Ribak et al.,
1996; Heja et al., 2009, 2012; Shigetomi et al., 2012). First,
we identified the proportion of tonic GABAA conductance in
interneurons that is mediated by non-vesicular GABA release. We
compared the tonic GABAA current in control slices and in slices
pretreated with a selective inhibitor of vacuolar H+-ATPases,
bafilomycin A1, which prevents GABA loading into synaptic
FIGURE 1 | NO711 and SNAP5114 have a synergistic effect on the tonic
GABAA current. (A) Changes in Ihold produced by SNAP5114 following
NO711 application (upper traces) and by NO711 following SNAP5114
application (lower traces). Dashed lines—baseline or drug-blocked levels of
Ihold; black line—application of NO711, gray line—application of SNAP5114.
(B) Summary graph of changes in Ihold produced by separate applications
and co-application of SNAP5114 and NO711, showing a strong interaction
between the two transporter antagonists (n = 6; F(1, 5) = 18.72, P < 0.01,
Two-Way ANOVA).
vesicles and thus vesicular GABA release. The slices pretreated
with bafilomycin A1 were completely devoid of sIPSCs, confirm-
ing total blockade of vesicular release (Figures 2A,B). In these
slices, application of picrotoxin revealed significant tonic GABAA
currents in CA1 interneurons (7.9 ± 2.8 pA, n = 6, P = 0.028
one-sample t-test), which constituted 40% of the tonic GABAA
current revealed by picrotoxin in control slices not treated with
bafilomycin A1 (19.6 ± 3.2 pA, n = 14, P = 0.015 one-sample
t-test; Figure 2C; P = 0.0031 for the difference between con-
trol and bafilomycin A1-treated slices, unpaired t-test). Because
picrotoxin also blocks homomeric glycine receptors, we con-
firmed that tonic current in bafilomycin A1-treated slices is
GABAergic using 25μM bicuculline (9.17 ± 2.40 pA, n = 6, P =
0.007 one-sample t-test; Figure 3A). Because bafilomycin A1 also
affects exocytosis and therefore can potentially affect the neuronal
receptor density (Johnson et al., 1993; Presley et al., 1997), we
tested whether the responses to exogenous GABA were affected
by bafilomycin A1 treatment. The tonic current produced by
exogenous application of 10μMGABA did not differ significantly
between control and treated slices (Figure 3B).
mGAT3/4 REGULATES GABA ORIGINATING FROM NON-VESICULAR
SOURCES
We then tested the effect of mGAT1 and mGAT3/4 blockers on
the tonic GABAA current in the presence of bafilomycin A1.
The mGAT1 blocker NO711 led to a smaller increase in the
tonic GABAA current in the absence of vesicular release (Table 1,
Figure 4A). However, the increase was significant (P = 0.007,
paired t-test), suggesting that mGAT1 limits the contribution
of both synaptic spillover and also non-vesicular release to
ambient GABA concentrations. In contrast, the tonic GABAA
FIGURE 2 | A proportion of the tonic GABAA current in hippocampal
interneurons is independent of vesicular GABA release. (A)
Representative traces showing picrotoxin (PTX)-sensitive tonic current
in a control slice and a slice treated with bafilomycin A1 (Baf. A1); black
line—PTX application. (B) Mean Ispont in control (n = 14) and
bafilomycin A1-treated slices (n = 6). (C) Mean tonic GABAA current
(Ihold, n = 14) in control and bafilomycin A1-treated slices (n = 6).
∗P < 0.05, ∗∗P < 0.01, unpaired t-test.
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current increase caused by mGAT3/4 blocker SNAP5114 was not
significantly different in the absence or presence of vesicular
release (Table 1, Figure 4B), suggesting that, in slices at base-
line conditions, mGAT3/4 regulates GABA originating largely
FIGURE 3 | Characteristics of the tonic GABAA current in
bafilomycin A1-treated slices. (A) 100μM picrotoxin (PTX, n = 6) and
25μM bicuculline (BMI, n = 5) revealed similar tonic GABAA current in CA1
interneurons of bafilomycin A1-treated slices. (B) Sensitivity of Ihold to
exogenous GABA (10μM) in control (n = 6) and bafilomycin A1-treated
slices (n = 7). Black circles—Ihold in control slices, white circles—Ihold in
bafilomycin A1-treated slices normalized to corresponding baseline values
(dashed line). Gray line—GABA application. N.S. P > 0.05, unpaired t-test.
FIGURE 4 | Tonic GABAA current mediated by non-vesicular GABA
release is regulated by mGAT3/4, but not by mGAT1. (A) Top: Changes
in Ihold produced by NO711 in control (upper trace) or
bafilomycin A1-treated slices (lower trace). Dashed line—baseline level of
Ihold, black line—application of NO711. Bottom: Summary graph showing
changes in Ihold produced by NO711 in control (ctrl, n = 6) and
bafilomycin A1-treated (Baf. A1, n = 6) slices. (B) Top: Changes in Ihold
produced by SNAP5114 in control (upper trace) or bafilomycin A1-treated
slices (lower trace). Dashed line—baseline level of Ihold, gray
line—application of SNAP5114. Bottom: Summary graph showing changes
in Ihold produced by SNAP5114 in control (ctrl, n = 7) and
bafilomycin A1-treated (Baf. A1, n = 6) slices. ∗P < 0.05; N.S. P > 0.05,
unpaired t-test.
from non-vesicular sources. We then asked whether the effect of
bafilomycin A1 depended on which type of GABA transporters
was blocked. Using a Two-Way ANOVA we found that the inter-
action between bafilomycin A1 and uptake inhibitor is significant
[F(1, 21) = 434, p = 0.025], indicating that bafilomycin A1 has a
significantly greater effect in the presence of a mGAT1 blocker
than mGAT3/4 blocker and suggesting also that mGAT1 mainly
controls the uptake of GABA released by exocytosis.
mGAT1 REGULATES GABA ORIGINATING FROM VESICULAR SOURCES
It remains possible, however, that when vesicular release is
increased, mGAT3/4 can contribute to the uptake of GABA
escaping from the synaptic cleft together with mGAT1. To test
this possibility, synaptic GABA release was enhanced with the
mutant α-latrotoxin (LTXN4C) which, unlike the wild-type toxin,
does not form pores in the membrane and increases neuro-
transmitter release by stimulating LTX receptors (most likely
latrophilin 1) without neuronal depolarization (Ichtchenko et al.,
1998; Capogna et al., 2003; Volynski et al., 2003; Deak et al.,
2009). LTXN4C at a concentration of 0.1 nM increased the fre-
quency of sIPSCs to 144.5 ± 10.5% of baseline (n = 7, P = 0.004
paired t-test; Figures 5A,B). As expected for LTXN4C, which acti-
vates latrophilin after a lag-period (Volynski et al., 2004), the
observed increase started 5min after drug application. No sig-
nificant change in the sIPSC amplitude was detected (107.6 ±
7.6% of baseline, n = 7, P = 0.178 paired t-test; Figure 5C),
indicating that LTXN4C did not affect the membrane perme-
ability of the post-synaptic cell. We next tested how changes in
vesicular GABA release affect the tonic GABAA current. LTXN4C
increased Ihold in the recorded cells to 117.9 ± 5.1% of baseline
FIGURE 5 | LTXN4C enhances spontaneous synaptic GABA release.
(A) Representative whole-cell recordings of sIPSC from an individual CA1
str. radiatum interneuron before (left) and 10min after (right) focal
application of LTXN4C. (B) LTXN4C effect on the mean sIPSC frequency
normalized to the baseline (dashed line, n = 7). Gray line—application of
LTXN4C. (C) LTXN4C effect on mean sIPSC amplitude normalized to the
baseline (dashed line, n = 7). Gray line—application of LTXN4C.
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(n = 6, P = 0.007 paired t-test; Figure 6A). The time-course of
this increase followed the time-course of the change in sIPSC fre-
quency (Figure 6A, compare to Figure 5B). The LTXN4C effect on
Ihold was blocked by picrotoxin (99.58 ± 7.27% of Ihold in picro-
toxin, n = 4, P = 0.29 paired t-test) or by bicuculline (100.9 ±
3.6 % of Ihold in bicuculline, n = 4, P = 0.48 paired t-test),
indicating that the observed change in Ihold was mediated by
FIGURE 6 | Tonic GABAA current produced by an increase in vesicular
GABA release is regulated by mGAT1, but not mGAT3/4. (A) Top:
Representative traces showing an increase in Ihold 10min after LTXN4C (gray
line). Bottom: Time-course of normalized Ihold before and during LTXN4C
application (n = 7). Dashed line—baseline Ihold, gray line—application of
LTXN4C. (B) Summary graphs showing an increase in tonic GABAA current
with increasing synaptic release (Ihold/Ispont). The increase in the
Ihold/Ispont ratio during NO711 (n = 6) application suggests that more
GABA escapes the synapses when mGAT1 is blocked. SNAP5114 (n = 7)
had no effect on the Ihold/Ispont ratio, suggesting that mGAT3/4 does not
regulate GABA escape from the synapses. ∗P < 0.05, N.S. P > 0.05,
unpaired t-test.
GABAA receptors (Figure 7). To estimate the proportion of the
tonic GABAA current produced by enhanced vesicular GABA
release, we calculated the ratio between the change in Ihold and
the change in Ispont [Ihold/Ispont, where Ispont is the time-
averaged current mediated by sIPSC calculated as the prod-
uct of the mean charge transfer of sIPSCs and their frequency
(Semyanov et al., 2003; Song et al., 2011)]. In control con-
ditions this ratio was 15.14 ± 4 (n = 8), suggesting that Ihold
changes by approximately 15 pA per 1 pA change in Ispont. When
GABA uptake is blocked, an increase in Ihold/Ispont ratio
would be expected, indicating that more GABA can escape the
synaptic cleft. Since IPSC shape (and thus Ispont) can change
in the presence of GABA uptake blockers, we added the uptake
blocker first and then measured the effect of LTXN4C. The
Ihold/Ispont ratio was increased approximately two-fold in the
presence of NO711 (37.20 ± 11.45, n = 7, P = 0.04 for differ-
ence from control, unpaired t-test), but was not significantly
affected in the presence of SNAP5114 (16.48 ± 6.67, n = 5,
P = 0.11 for difference from control, unpaired t-test), suggest-
ing that mGAT1, but not mGAT3/4, is responsible for limiting
GABA spillover, even with increased levels of synaptic release
(Figure 6B).
DISCUSSION
Our results demonstrate that mGAT1 and mGAT3/4 transporter
types are associated with two different extrasynaptic signaling
pathways. mGAT1, but not mGAT3/4, limits synaptic GABA
spillover. In contrast, mGAT3/4 makes a larger contribution than
mGAT1 to the regulation of GABA released from extrasynaptic
sources (Zilberter et al., 1999; Kozlov et al., 2006; Lee et al., 2010).
The different roles of mGAT1 and mGAT3/4 in the regula-
tion of extrasynaptic GABA sources can be explained by their
FIGURE 7 | LTXN4C-mediated increase in Ihold is blocked by GABAA
receptor antagonists. (A) Top: Representative traces showing that
picrotoxin (PTX, black solid line) completely blocks the increase in Ihold
produced by LTXN4C (gray line). Dashed line—baseline Ihold. Bottom: Effect
of PTX and LTXN4C on Ihold normalized to the baseline (dashed line, n = 4).
Solid black line—application of PTX, solid gray line—application of LTXN4C.
(B) Top: Representative traces showing no increase in Ihold by LTXN4C
(gray line) in the presence of bicuculline (BMI, black solid line). Dashed
line—baseline Ihold.Bottom: Effect of BMI and LTXN4C on Ihold normalized to
the baseline (dashed line, n = 4). Solid black line—application of BMI, solid
gray line—application.
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cellular localization. In rat hippocampus, rGAT1 is expressed
predominantly in neurons, which express no or only low lev-
els of rGAT3 (Ribak et al., 1996; Heja et al., 2009). In contrast,
rGAT3 is strongly expressed in rat hippocampal astrocytes (Heja
et al., 2012; Shigetomi et al., 2012). The cell-type specific local-
ization of mGAT1 and mGAT3/4 is responsible for the different
regulation of IPSCs by these transporter types. rGAT1 blocker,
but not rGAT2/3 blocker, prolongs the decay time of evoked
IPSCs in rat neocortex (Keros and Hablitz, 2005) and striatal
output neurons (Kirmse et al., 2009). In contrast, in rat globus
pallidus, both rGAT1 and rGAT2/3 blockers affect the kinet-
ics of evoked IPSCs (Jin et al., 2011). The interpretation of
the transporter blocker effects on synaptic signaling is compli-
cated by possible changes in the presynaptic release probability
or in the presynaptic excitability due to elevated ambient GABA
concentrations.
Notably, expression patterns of the two transporter types
can change independently during physiologic processes, such as
memory formation (Tellez et al., 2012), and pathologic processes,
such as epilepsy (Cope et al., 2009). In addition to transporter
expression, the two GABA uptake systems can be individu-
ally regulated by endogenous modulators. For example, zinc, a
potent inhibitor of rGAT4, can be released in the hippocam-
pus together with glutamate (Cohen-Kfir et al., 2005). Indeed,
zinc increases the extracellular GABA concentration in the hip-
pocampus (Takeda et al., 2004). In addition, glutamate uptake
by astrocytes increases the intracellular sodium concentration in
these cells (Kirischuk et al., 2012). Increased sodium, in turn,
decreases the efficiency of (or even reverses) sodium-dependent
GABA uptake by astrocytic rGAT2/3 transporters in the rat (Heja
et al., 2012). Such uptake modulation of ambient GABA released
from non-vesicular sources would allow for high levels of glu-
tamatergic synaptic excitation to increase tonic GABAA conduc-
tance in the hippocampus without affecting synaptic GABAergic
signaling.
Taken together with our findings, these considerations sug-
gest the existence of two functionally distinct extrasynaptic GABA
signaling systems that possess independently regulated uptake
machinery. One system is directly operated by GABA escape from
the GABAergic synapses and is associated with mGAT1. This
system provides direct feedback regulation of GABAergic synap-
tic activity through regulating the tonic GABAA conductance.
The second system is operated by other neurotransmitters that
can promote non-vesicular GABA release (e.g., by astrocytes),
and is regulated by mGAT3/4. This system represents an indi-
rect network feedback (via non-vesicular GABA release), which
also results in changes in tonic GABAA conductance. Notably,
when one of the transporter types is blocked the second type
compensates for its loss and takes up GABA originating from
both sources. Therefore, when both transporters are blocked their
effect on tonic GABAA conductance is supra-additive. This opens
up the possibility that in cases when GABA release from the
vesicular or non-vesicular source overwhelms their “dedicated”
transporter type, the other transporter type can assist in GABA
clearance. However, we did not find that a moderate increase
in vesicular GABA release can overwhelm mGAT1, but it could
potentially happen with further increases in GABA release, or in
situations when there is a downregulation of mGAT1.
Importantly, we performed the experiments with GABAB
receptors blocked. Activation of these receptors may also depend
on the source of extracellular GABA. Indeed, different roles
played by rGAT1 and rGAT3 in regulating GABAB recep-
tor activation have been shown in thalamus (Beenhakker and
Huguenard, 2010). Thus two GABA sources and two types
of GABA transporters can form a specific agonist “tem-
plate” for extrasynaptic GABAA and GABAB receptor activation
(Semyanov, 2008).
Another important question is the identity of the recorded
interneurons. We identified these cells solely by their location
in CA1 str.radiatum and non-pyramidal shape, and did not
differentiate different interneuronal subtypes (Klausberger and
Somogyi, 2008). It is possible that distinct interneurons may
express tonic GABAA currents to differing extents as has been
shown in neocortex (Vardya et al., 2008). Potentially, the con-
tribution of vesicular and non-vesicular sources of GABA may
also differ among different interneuron subtypes and so tonic
GABAA conductances could be regulated differently by the two
transporter systems. This question is an important subject for
future functional studies, especially those which aim to apply our
finding to the identification of novel drug targets. Indeed, the
functional difference between mGAT1 and mGAT3/4 prompts a
refinement of therapeutic targets for drugs acting on the GABA
uptake systems. For example, the anti-epileptic drug, tiagabine, a
mGAT1 blocker, increases GABA spillover, and can affect the time
course of IPSCs (Walker and Kullmann, 2012). Because IPSCs
are involved in synaptic computations, tiagabine can poten-
tially have unwanted effects on synaptic network operation. A
selective mGAT3/4 transporter blocker should increase extracel-
lular GABA levels without significantly affecting synaptic com-
munication and perhaps lack the side effects characteristic of
tiagabine.
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